These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 4001904)
1. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?]. Reinhardt D; Hofmann V; Martz G Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904 [TBL] [Abstract][Full Text] [Related]
2. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer. Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034 [TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer. Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895 [TBL] [Abstract][Full Text] [Related]
5. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B; Bode U; von Schweinitz D Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356 [TBL] [Abstract][Full Text] [Related]
6. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III]. Bustová I Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435 [TBL] [Abstract][Full Text] [Related]
7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
8. Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety. Catimel G; Spielmann M; Dieras V; Kayitalire L; Pouillart P; Guastalla JP; Soler-Michel P; Graffand N; Garet F; Dumortier A; Pellae-Cosset B; Chazard M Semin Oncol; 1996 Feb; 23(1 Suppl 1):24-7. PubMed ID: 8629032 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval). Greco FA; Brereton HD; Rodbard D Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446 [TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity in long term treatment with cytostatics (author's transl)]. Fuhrmann U; Rieger M; Franz Ch Dtsch Med Wochenschr; 1978 Mar; 103(9):387-90. PubMed ID: 272983 [TBL] [Abstract][Full Text] [Related]
11. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG). Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710 [TBL] [Abstract][Full Text] [Related]
12. [Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin]. Geidel S; Garn M; Grävinghoff L; Hausdorf G; Morf G; Bielack S; Knop J; Winkler K Klin Padiatr; 1991; 203(4):257-61. PubMed ID: 1942931 [TBL] [Abstract][Full Text] [Related]
13. Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinations. Sparano JA Semin Oncol; 1998 Aug; 25(4 Suppl 10):66-71. PubMed ID: 9768827 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel plus doxorubicin in metastatic breast cancer: preliminary analysis of cardiotoxicity. Martin M; Lluch A; Ojeda B; Barnabas A; Colomer R; Massuti B; Benito D Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-26-S17-30. PubMed ID: 9374088 [TBL] [Abstract][Full Text] [Related]
16. Treatment of metastatic breast cancer with paclitaxel and doxorubicin. Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964 [TBL] [Abstract][Full Text] [Related]
17. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases]. Wang SQ Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G; J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer. Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BV Semin Oncol; 1996 Feb; 23(1 Suppl 1):13-8. PubMed ID: 8629030 [TBL] [Abstract][Full Text] [Related]
20. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Swain SM; Whaley FS; Ewer MS Cancer; 2003 Jun; 97(11):2869-79. PubMed ID: 12767102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]